Amicogen, Inc. (092040.KQ)
KRW 3930.0
(-3.2%)
KRW 3930.0
(-3.2%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 149.59 Billion KRW | 3.54% |
| 2022 | 144.47 Billion KRW | 70.53% |
| 2021 | 84.72 Billion KRW | 95.66% |
| 2020 | 43.3 Billion KRW | 8.26% |
| 2019 | 39.99 Billion KRW | 14.59% |
| 2018 | 34.9 Billion KRW | 49.56% |
| 2017 | 23.33 Billion KRW | 3.14% |
| 2016 | 22.62 Billion KRW | -11.37% |
| 2015 | 25.53 Billion KRW | 31814.95% |
| 2014 | 80 Million KRW | 0.0% |
| 2013 | - KRW | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 175.32 Billion KRW | -1.12% |
| 2024 Q1 | 177.3 Billion KRW | 18.52% |
| 2023 Q4 | 149.59 Billion KRW | -17.41% |
| 2023 FY | 149.59 Billion KRW | 3.54% |
| 2023 Q1 | 164.9 Billion KRW | 14.14% |
| 2023 Q2 | 164.92 Billion KRW | 0.02% |
| 2023 Q3 | 181.12 Billion KRW | 9.82% |
| 2022 Q2 | 125.25 Billion KRW | 11.6% |
| 2022 Q3 | 143.9 Billion KRW | 14.89% |
| 2022 FY | 144.47 Billion KRW | 70.53% |
| 2022 Q1 | 112.23 Billion KRW | 32.47% |
| 2022 Q4 | 144.47 Billion KRW | 0.4% |
| 2021 Q2 | 105.09 Billion KRW | 120.22% |
| 2021 Q4 | 84.72 Billion KRW | -21.87% |
| 2021 Q3 | 108.44 Billion KRW | 3.18% |
| 2021 FY | 84.72 Billion KRW | 95.66% |
| 2021 Q1 | 47.72 Billion KRW | 11.53% |
| 2020 Q2 | 45.31 Billion KRW | 2.62% |
| 2020 Q3 | 43.45 Billion KRW | -4.09% |
| 2020 FY | 43.3 Billion KRW | 8.26% |
| 2020 Q1 | 44.15 Billion KRW | 13.84% |
| 2020 Q4 | 42.78 Billion KRW | -1.54% |
| 2019 Q3 | 39.63 Billion KRW | 9.79% |
| 2019 Q2 | 36.09 Billion KRW | 1.26% |
| 2019 Q1 | 35.64 Billion KRW | 2.12% |
| 2019 FY | 39.99 Billion KRW | 14.59% |
| 2019 Q4 | 38.78 Billion KRW | -2.12% |
| 2018 Q4 | 34.9 Billion KRW | 4.44% |
| 2018 Q2 | 35.21 Billion KRW | 46.16% |
| 2018 Q1 | 24.09 Billion KRW | 3.24% |
| 2018 FY | 34.9 Billion KRW | 49.56% |
| 2018 Q3 | 33.42 Billion KRW | -5.1% |
| 2017 Q3 | 18.78 Billion KRW | -21.66% |
| 2017 Q4 | 23.33 Billion KRW | 24.22% |
| 2017 FY | 23.33 Billion KRW | 3.14% |
| 2017 Q1 | 25.16 Billion KRW | 11.21% |
| 2017 Q2 | 23.98 Billion KRW | -4.69% |
| 2016 Q1 | 17.85 Billion KRW | -30.07% |
| 2016 FY | 22.62 Billion KRW | -11.37% |
| 2016 Q4 | 22.62 Billion KRW | 12.52% |
| 2016 Q3 | 20.11 Billion KRW | -0.95% |
| 2016 Q2 | 20.3 Billion KRW | 13.72% |
| 2015 Q3 | 33.76 Billion KRW | 42100.21% |
| 2015 Q2 | 80 Million KRW | 0.0% |
| 2015 Q1 | 80 Million KRW | 0.0% |
| 2015 FY | 25.53 Billion KRW | 31814.95% |
| 2015 Q4 | 25.53 Billion KRW | -24.37% |
| 2014 FY | 80 Million KRW | 0.0% |
| 2014 Q4 | 80 Million KRW | 0.0% |
| 2014 Q2 | 570 Million KRW | 0.0% |
| 2014 Q1 | - KRW | 0.0% |
| 2014 Q3 | 80 Million KRW | -85.96% |
| 2013 FY | - KRW | 0.0% |
| 2013 Q3 | 1.73 Billion KRW | 0.0% |
| 2013 Q4 | - KRW | -100.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| HLB Co., Ltd. | 62.7 Billion KRW | -138.568% |
| iNtRON Biotechnology, Inc. | 402.9 Million KRW | -37028.702% |
| BINEX Co., Ltd. | 53.5 Billion KRW | -179.58% |
| Bioneer Corporation | 44.63 Billion KRW | -235.115% |
| Anterogen.Co.,Ltd. | 9.74 Billion KRW | -1435.821% |
| MEDIPOST Co., Ltd. | 52.33 Billion KRW | -185.826% |
| CrystalGenomics, Inc. | 32 Billion USD | -367.439% |
| Helixmith Co., Ltd | 20.22 Billion KRW | -639.555% |
| Chabiotech Co.,Ltd. | 449.63 Billion KRW | 66.73% |
| Medy-Tox Inc. | 82.83 Billion KRW | -80.605% |
| Peptron, Inc. | 9.13 Billion KRW | -1537.964% |
| Genexine, Inc. | 67.42 Billion KRW | -121.862% |
| HLB Therapeutics Co.,Ltd. | 10.02 Billion KRW | -1392.615% |
| LegoChem Biosciences, Inc. | 12.64 Billion KRW | -1083.137% |
| ALTEOGEN Inc. | 83.76 Billion KRW | -78.58% |
| PharmaResearch Co., Ltd. | 34.3 Billion KRW | -336.052% |
| SillaJen, Inc. | 9.69 Billion KRW | -1442.755% |
| JETEMA, Co., Ltd. | 130.49 Billion KRW | -14.635% |
| OliX Pharmaceuticals,Inc | 39.35 Billion KRW | -280.094% |
| Genomictree Inc. | 1.83 Billion KRW | -8053.841% |
| MedPacto, Inc. | 8.6 Billion KRW | -1638.646% |
| D&D Pharmatech | 8.13 Billion KRW | -1739.064% |
| EASY BIO,Inc. | 82.27 Billion KRW | -81.817% |
| GI Innovation, Inc. | 3.72 Billion KRW | -3920.474% |